Constantin-Teodosiu D, Young S, Wellock F, Short AH, Burden RP, Morgan AG, Greenhaff PL: Gender and age differences in plasma carnitine, muscle strength, and exercise tolerance in haemodialysis patients
Adults are expected to lead the end user segment with a 65% market share in 2025
The pharmacokinetic profile of liraglutide, which makes it suitable for once-daily administration, is a result of self-association that delays absorption, plasma protein binding, and stability against metabolic degradation by DPP-4 and NEP
This process is irreversible refrigerating the peptide after thermal exposure does not refold it into the bioactive conformation